Author

E. Jang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

B.-S. Han· 1 shared D. Kim· 1 shared E.-W. Lee· 1 shared G.-S. Hwang· 1 shared H. Y. Son· 1 shared J. Seo· 1 shared J. W. Kim· 1 shared J.-Y. Lee· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B.-S. Han

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Darapladib, an inhibitor of Lp-PLA2, sensitizes cancer cells to ferroptosis by remodeling lipid metabolism

M. Oh, S. Y. Jang, J.-Y. Lee, J. W. Kim, Y. Jung, J. Seo, T.-S. Han, E. Jang, H. Y. Son, D. Kim, M. W. Kim, K.-H. Song, K.-J. Oh, W. K. Kim, K.-H. Bae, , E.-W. Lee

This study shows that darapladib, an Lp-PLA2 inhibitor, enhances ferroptosis in cancer cells by altering lipid metabolism and synergizes with GPX4 inhibitors to suppress tumor growth.

bioRxiv · Apr 8, 2023 · PreprintCancer Biology